[199 Pages Report] The Hemostats Market size was estimated at USD 3.23 billion in 2023 and expected to reach USD 3.42 billion in 2024, at a CAGR 5.65% to reach USD 4.75 billion by 2030.
The hemostats are a range of medical devices and products designed to control, prevent, and stop bleeding during surgical procedures and traumatic injuries. These devices play an important role in managing blood loss and facilitate proper tissue healing while reducing the risk of complications. Hemostats have applications in numerous surgical specialties, including cardiovascular surgery, general surgery, orthopedic surgery, neurosurgery, gynecologic surgery, and dental surgery. The growing occurrence of chronic diseases among an aging population drives the demand for surgeries that necessitate effective blood loss management solutions, consequently expanding the utilization of diverse hemostatic agents. Additionally, increasing inclination toward minimally invasive procedures with rising investments by government bodies and healthcare organizations to improve surgical infrastructure is raising the usage of hemostats. High R&D costs associated with developing breakthrough products and a high risk of contamination with hemostats hamper market growth. The increasing development of biologically compatible hemostats by market vendors that minimize adverse effects while providing effective bleeding control is expected to create opportunities for market growth.
The growing number of surgical procedures with the rising availability of advanced healthcare facilities, especially across the U.S., Canada, and Brazil, are expanding the growth of the hemostats market in the Americas. According to the American Society of Plastic Surgeons, in 2022, a total of 1,017,003 reconstructive surgeries were performed, necessitating the use of hemostats. The emerging trend of medical tourism across Canada, Dubai, Singapore, Japan, and the UK is expanding the number of minimally invasive surgical procedures, thereby creating a platform for the hemostats market. According to the Medical Tourism Index survey (MTA), Canada is one of the preferred destinations, attracting around 14 million Americans from other nations. Ongoing advancements in healthcare infrastructure and technologies across European countries, with constant support from regulatory bodies such as the European Medicines Agency (EMA) on expanding the manufacturing of medical devices and healthcare infrastructure, are bolstering the European market. The Middle East & Africa region presents promising growth opportunities due to increasing healthcare expenditure and government initiatives towards modernizing healthcare infrastructure. Countries, including Saudi Arabia, the United Arab Emirates, and South Africa, are witnessing a surge in the need for effective hemostatic solutions with the rising number of surgical interventions. Moreover, increased government funding to expand the manufacturing of medical devices domestically across India, Australia, China, and Japan and increased awareness associated with minimally invasive surgeries are expected to bolster market growth in Asia-Pacific.
Collagen-based hemostats are derived from purified collagen; they are known for their excellent biocompatibility and ability to accelerate clot formation by initiating platelet aggregation. These hemostats are often preferred in surgeries involving soft tissues and delicate structures, such as neurosurgery and ophthalmic surgery. Combination hemostats consist of two or more active agents that work synergistically to enhance hemostatic efficacy. They typically combine the benefits of hemostats, such as collagen-based, gelatin-based, and thrombin-based products. The demand for combination hemostats is growing due to their increased effectiveness in minimizing bleeding complications during complex surgical procedures. Oxidized regenerated cellulose-based hemostats are made from plant-derived cellulose that undergoes oxidation and regeneration processes. They possess antimicrobial properties and effectively control bleeding by creating a physical barrier between blood vessels and surrounding tissues. ORC-based hemostats are often used in dental surgeries, gastrointestinal surgeries, and gynecological procedures. Thrombin-based hemostats contain human or bovine thrombin as their active ingredient, which activates the coagulation cascade, resulting in rapid clot formation. They are particularly useful in controlling bleeding where traditional techniques may be ineffective or impractical, such as cardiovascular surgeries or organ transplantations. The collagen-based hemostats provide excellent biocompatibility and are often preferred for delicate surgeries. Combination hemostats offer increased effectiveness due to their synergistic properties. Gelatin-based hemostats are valued for their rapid blood clotting ability in critical situations. ORC-based hemostats exhibit antimicrobial properties and create a physical barrier for bleeding control, while thrombin-based hemostats activate the coagulation cascade for rapid clot formation.
Matrix and gel hemostats are biocompatible, absorbable materials that facilitate rapid clot formation. They are preferred in situations where the application of direct pressure during surgery is difficult, such as in minimally invasive procedures. Powder hemostats work by absorbing fluid from bleeding tissue and enhancing platelet aggregation. Their ease of application makes them suitable for various surgical specialties, including general, orthopedic, cardiovascular, and neurosurgery. Sheet and pad hemostats are flexible bioabsorbable materials, allowing for better conformity to irregular wound surfaces. They are utilized in surgeries where larger areas need to be covered, and suturing is challenging. Sponge hemostats are highly absorbent materials easily molded into various shapes, making them suitable for irregular wound cavities. They are commonly used in dental and oral surgeries, as well as neurosurgery and cardiovascular surgery. Matrix & gel hemostats provide rapid clot formation in hard-to-reach areas, whereas powder hemostats offer easy application across surgical specialties. Sheet & pad hemostats conform to irregular wound surfaces covering larger areas; then, sponge hemostats provide excellent absorbency and moldability for irregular wound cavities.
Cardiovascular surgeries involve high blood flow, arteries, and veins, often requiring efficient hemostatic solutions to prevent excessive bleeding. Hemostats are widely preferred in these procedures due to their rapid action and ability to achieve effective hemostasis. In general surgery, the use of hemostats plays a significant role in wound management and ensuring minimum blood loss during procedures such as appendectomy and hernia repair. Gynecological surgeries often require meticulous control of bleeding during delicate procedures such as hysterectomy and myomectomy. Hemostats have effectively minimized adhesions while providing adequate hemostasis during these surgeries. Hemostats are specifically designed to address this need while preserving neural structures. Orthopedic surgeries, including joint replacements and fracture fixation, require robust hemostatic agents as they involve cutting through dense bone and connective tissues. In reconstructive surgery, which includes skin grafting and flap reconstruction, managing blood loss becomes critical for successful outcomes. Hemostatic agents are preferred in these cases due to their adaptability across different tissues and ability to seal large wounds effectively. Compared to other applications, cardiovascular surgeries show a higher need-based preference for advanced hemostatic agents.
The market dynamics represent an ever-changing landscape of the Hemostats Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Hemostats Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Hemostats Market.
The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Hemostats Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.
The value chain of the Hemostats Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.
The pricing analysis comprehensively evaluates how a product or service is priced within the Hemostats Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Hemostats Market.
The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Hemostats Market.
The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Hemostats Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.
The trade analysis of the Hemostats Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.
The regulatory framework analysis for the Hemostats Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hemostats Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hemostats Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+ Hemostatic Device Usage in Cardiac Surgical Procedures
Teleflex Incorporated received clearance from the U.S. Food and Drug Administration (FDA) for the QuikClot Control+ Hemostatic Device. This device is now approved for use in cardiac surgical procedures to address mild and moderate bleeding, as well as bone surface bleeding after a sternotomy. [Published On: 2023-08-01]
Baxter Launches PERCLOT Absorbable Hemostatic Powder
Baxter International Inc. introduced PERCLOT Absorbable Hemostatic Powder in the U.S., a passive hemostatic powder designed for patients with intact coagulation. PERCLOT's granules effectively absorb water, forming a gelled adhesive matrix that acts as a mechanical barrier against further bleeding. This process promotes the accumulation of platelets, red blood cells, and coagulation proteins, aiding in the hemostatic process. [Published On: 2023-07-24]
Artivion Gains FDA Approval for PerClot, Starts Transfer to Baxter
Artivion, Inc. has received FDA premarket application approval for its absorbable hemostatic system, PerClot. In July 2021, Baxter acquired full ownership of PerClot through a sale agreement. The FDA approval of PerClot, Artivion represents a significant step ahead in optimizing patient care by addressing intraoperative bleeding. [Published On: 2023-05-24]
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hemostats Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
The report delves into recent significant developments in the Hemostats Market, highlighting leading vendors and their innovative profiles. These include A.R. Medicom, Inc., ACTEON Group, Advamedica Inc., Advanced Medical Solutions Group PLC, Advin Health Care, Aegis Lifesciences Private Limited, Argon Medical Devices, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Betatech Medical, Convatec Group PLC, Cook Group Incorporated, Cortis Medtech Pvt Ltd, Cotran Corporation, Dolphin Sutures by Futura Surgicare Pvt. Ltd., Dynarex Corporation, Gelita AG, Hangzhou Singclean Medical Products Co.,Ltd., Healthium Medtech Ltd, Hemostasis, LLC, Integra LifeSciences Holdings Corporation, Johnson & Johnson Services, Inc., Medcura, Inc., Medline Industries, LP, Medprin Biotech GmbH, Medtronic PLC, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Pfizer Inc., Rousselot BV by Darling Ingredients International Holding B.V., Royal DSM, Shilpa Medicare Limited, Stapleline Medizintechnik GmbH, Stryker Corporation, SYMATESE, Teleflex Incorporated, Terumo Corporation, Zhejiang Perfectseal New Material Technology Co., Ltd., and Zimmer Biomet Holdings, Inc..
This research report categorizes the Hemostats Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Type
- Collagen-Based Hemostats
- Combination Hemostats
- Gelatin-Based Hemostats
- Oxidized Regenerated Cellulose-Based Hemostats
- Thrombin-Based Hemostats
- Formulation
- Matrix & Gel Hemostats
- Powder Hemostats
- Sheet & Pad Hemostats
- Sponge Hemostats
- Application
- Cardiovascular Surgery
- General Surgery
- Gynecological Surgery
- Neurological Surgery
- Orthopedic Surgery
- Reconstructive Surgery
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
- Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
- Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
- Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
- Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
- Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.
- What is the current market size and projected growth?
- Which products, segments, applications, and regions offer promising investment opportunities?
- What are the prevailing technology trends and regulatory frameworks?
- What is the market share and positioning of the leading vendors?
- What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?
- Preface
- Research Methodology
- Executive Summary
- Market Overview
- Market Insights
- Hemostats Market, by Type
- Hemostats Market, by Formulation
- Hemostats Market, by Application
- Americas Hemostats Market
- Asia-Pacific Hemostats Market
- Europe, Middle East & Africa Hemostats Market
- Competitive Landscape
- Competitive Portfolio
- List of Figures [Total: 22]
- List of Tables [Total: 298]
- List of Companies Mentioned [Total: 40]
Hemostats are medical devices that assist in controlling bleeding during surgical procedures. They are designed to be used as a primary means of achieving hemostasis or as an adjunct to other techniques. Hemostats interact with blood coagulation factors to form a clot, halting bleeding at the surgical site. Hemostats come in different types, including mechanical, absorbable, and topical Hemostats. The choice of Hemostat depends on various factors, including the surgical procedure, the patient's coagulation status, and the surgeon's preference.
In minimally invasive surgeries, using Hemostats becomes even more crucial because the surgical site is often challenging to visualize, access, and control. Hemostats help surgeons achieve quick hemostasis, reduce the risk of bleeding complications, and allow for a more efficient surgical procedure. Furthermore, Hemostats can also reduce the overall surgery costs by shortening the overall length of surgical time in cases of unexpected bleeding.
Mechanical Hemostats, or Hemostatic Clips, are the most commonly used Hemostats in minimally invasive surgeries. These Hemostats are applied at the bleeding site using a delivery device inserted through a small incision site. Hemostatic clips provide quick and efficient hemostasis, and their application is straightforward in most surgeries. Additionally, Hemostatic clips can be applied at a distance from the bleeding site, making them ideal for managing bleeding from a small-diameter vessel.
Topical Hemostats are absorbable or non-absorbable agents designed to control bleeding by forming a blood clot. These Hemostats provide a matrix as a scaffold for the body's natural clotting mechanism. Topical Hemostats come in different forms, including powders, sprays, and gels, and can be applied directly to the bleeding site. One of the primary benefits of topical Hemostats is their ability to reach and stop bleeding in challenging-to-reach or awkward spaces that Hemostatic clips cannot reach.
Using Hemostats is essential in achieving successful minimally invasive surgeries. Hemostats help surgeons achieve quick hemostasis, reduce the risk of bleeding complications, and allow for a more efficient surgical procedure. With the growing demand for minimally invasive surgeries in the healthcare industry, using Hemostats is becoming more crucial than ever. As new technologies emerge in the surgical industry, developments and innovations in Hemostats will continue to advance, leading to better patient outcomes.
- How big is the Hemostats Market?
- What is the Hemostats Market growth?
- When do I get the report?
- In what format does this report get delivered to me?
- How long has 360iResearch been around?
- What if I have a question about your reports?
- Can I share this report with my team?
- Can I use your research in my presentation?